Crossmark

Phase II trial of induction chemotherapy with carboplatin and paclitaxel plus bevacizumab in patients with stage IIIA to IV nonsquamous non-small cell lung cancer

Crossref DOI link: https://doi.org/10.1007/s00595-019-01791-z

Published Online: 2019-03-02

Published Print: 2019-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Imai, Kazuhiro https://orcid.org/0000-0003-4490-7862
Nakagawa, Taku

Matsuzaki, Ikuo

Orino, Kimito

Saito, Hajime

Sato, Kazuhiro

Sano, Masaaki

Nakayama, Katsutoshi

Sato, Yusuke

Motoyama, Satoru

Nomura, Kyoko

Shibata, Hiroyuki

Minamiya, Yoshihiro
License Information

Text and Data Mining valid from 2019-03-02
More Information

Article History

Received: 7 January 2019

Accepted: 1 February 2019

First Online: 2 March 2019

Compliance with ethical standards

:

: We have no financial conflicts of interest to declare.

Document is current

Any future updates will be listed below